Can Intermittent Fasting Mimic the Metabolic and Cardiovascular and Anti-aging Effects of Calorie Restriction?

Washington University School of Medicine1 site in 1 country50 target enrollmentJuly 2013

ConditionsObesity Overweight

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Obesity
Sponsor: Washington University School of Medicine
Enrollment: 50
Locations: 1
Primary Endpoint: Change in HSCRP ( high sensitivity C-reactive protein) at 6 and 12 months
Status: Completed
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of Intermittent Fasting study is to investigate whether intermittent fasting could decrease the chronic inflammation levels in overweight/obese people.

Detailed Description

The primary objective of this study is to determine whether or not IF reduces the level of chronic inflammation as evidenced by a decrease in high sensitive C-reactive protein (hsCRP), as the main outcome measure

Registry

clinicaltrials.gov

Start Date

July 2013

End Date

September 2016

Last Updated

4 years ago

Study Type

Interventional

Study Design

Crossover

Sex

All

Investigators

Sponsor

Washington University School of Medicine

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•The participants in this study will be 50 men and women in the 30 to 65 year age range, who have a BMI in the high normal to moderately obese range (i.e. 24 to 35 kg/m2),
•Participants who are eating usual US diets and are sedentary to moderately active (i.e. not exercise trained).

Exclusion Criteria

•History of any chronic disease process that could interfere with interpretation of results
•Smoking, pregnancy, alcoholism, psychiatric problems, life situations that would interfere with study participation and compliance.